Announcement on Subsidiary Receiving Approval Notice for Marketing Application of Chemical Active Pharmaceutical Ingredient

About this update from Zhejiang Medicine Co., Ltd. Class A

Announcement on Subsidiary Receiving Approval Notice for Marketing Application of Chemical Active Pharmaceutical IngredientThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:" target="_blank">View Attachment

View stock analysis, news, and events for Zhejiang Medicine Co., Ltd. Class A